BIOMAT Database Logo BIOMAT Database Logo

Light-chain proteinuria and reversible renal failure in rifampin-treated patients with tuberculosis. 1976

S Kumar, and J A Mehta, and H L Trivedi

UI MeSH Term Description Entries
D007147 Immunoglobulin Light Chains Polypeptide chains, consisting of 211 to 217 amino acid residues and having a molecular weight of approximately 22 kDa. There are two major types of light chains, kappa and lambda. Two Ig light chains and two Ig heavy chains (IMMUNOGLOBULIN HEAVY CHAINS) make one immunoglobulin molecule. Ig Light Chains,Immunoglobulins, Light-Chain,Immunoglobulin Light Chain,Immunoglobulin Light-Chain,Light-Chain Immunoglobulins,Chains, Ig Light,Chains, Immunoglobulin Light,Immunoglobulins, Light Chain,Light Chain Immunoglobulins,Light Chain, Immunoglobulin,Light Chains, Ig,Light Chains, Immunoglobulin,Light-Chain, Immunoglobulin
D007538 Isoniazid Antibacterial agent used primarily as a tuberculostatic. It remains the treatment of choice for tuberculosis. Isonicotinic Acid Hydrazide,Ftivazide,Isonex,Isonicotinic Acid Vanillylidenehydrazide,Phthivazid,Phthivazide,Tubazide,Acid Vanillylidenehydrazide, Isonicotinic,Hydrazide, Isonicotinic Acid,Vanillylidenehydrazide, Isonicotinic Acid
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011507 Proteinuria The presence of proteins in the urine, an indicator of KIDNEY DISEASES. Proteinurias
D004977 Ethambutol An antitubercular agent that inhibits the transfer of mycolic acids into the cell wall of the tubercle bacillus. It may also inhibit the synthesis of spermidine in mycobacteria. The action is usually bactericidal, and the drug can penetrate human cell membranes to exert its lethal effect. (From Smith and Reynard, Textbook of Pharmacology, 1992, p863) Dexambutol,EMB-Fatol,EMB-Hefa,Etambutol Llorente,Ethambutol Hydrochloride,Etibi,Miambutol,Myambutol,EMB Fatol,EMB Hefa,Hydrochloride, Ethambutol,Llorente, Etambutol
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D012293 Rifampin A semisynthetic antibiotic produced from Streptomyces mediterranei. It has a broad antibacterial spectrum, including activity against several forms of Mycobacterium. In susceptible organisms it inhibits DNA-dependent RNA polymerase activity by forming a stable complex with the enzyme. It thus suppresses the initiation of RNA synthesis. Rifampin is bactericidal, and acts on both intracellular and extracellular organisms. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1160) Rifampicin,Benemycin,Rifadin,Rimactan,Rimactane,Tubocin

Related Publications

S Kumar, and J A Mehta, and H L Trivedi
Insidious rifampin-associated renal failure with light-chain proteinuria.
July 1977, Archives of internal medicine,
S Kumar, and J A Mehta, and H L Trivedi
Light chain proteinuria and cellular mediated immunity in rifampin treated patients with tuberculosis.
April 1975, Chest,
S Kumar, and J A Mehta, and H L Trivedi
Light chain proteinuria and humoral immunoincompetence in tuberculous patients treated with rifampin.
May 1973, The American review of respiratory disease,
S Kumar, and J A Mehta, and H L Trivedi
Rifampicin induced light chain proteinuria and renal failure.
December 1984, Thorax,
S Kumar, and J A Mehta, and H L Trivedi
Light-chain nephropathy. Renal tubular dysfunction associated with light-chain proteinuria.
January 1976, The New England journal of medicine,
S Kumar, and J A Mehta, and H L Trivedi
Reversible nephrotic range proteinuria and renal failure in atheroembolic renal disease.
January 1990, The American journal of the medical sciences,
S Kumar, and J A Mehta, and H L Trivedi
Light chain cast nephropathy and acute renal failure associated with rifampin therapy. Renal disease akin to myeloma kidney.
May 1987, The American journal of medicine,
S Kumar, and J A Mehta, and H L Trivedi
Acute renal failure presenting as Fanconi syndrome with lambda light chain proteinuria and interstitial nephritis.
May 1989, Clinical nephrology,
S Kumar, and J A Mehta, and H L Trivedi
["Reversible cholelithiasis" in patients with chronic renal failure treated with ceftriaxone].
November 1997, Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego,
S Kumar, and J A Mehta, and H L Trivedi
Fanconi syndrome with renal tubular acidosis and light chain proteinuria.
January 1971, Nephron,
Copied contents to your clipboard!